Individuals who’ve been vaccinated and those vaccinated who’ve also gotten a booster are less likely to become infected by either Omicron or stealth Omicron, the study states.
A subvariant of Omicron, dubbed “stealth Omicron” is “substantially” more transmissible than the original variant and poses a greater threat to vaccinated and booster-upped individuals, according to a study by Danish investigators that has not yet been peer reviewed. The original Omicron is BA.1; the stealth Omicron is BA.2.
“We conclude that Omicron BA.2 is inherently substantially more transmissible than BA.1, and that it also possesses immune-evasive properties that further reduce the protective effect of vaccination against infection, but do not increase its transmissibility from vaccinated individuals with breakthrough infections,” states the study, which was published on medRxiv website.
Investigators with the University of Copenhagen analyzed data taken from 8541 Danish households between December 20, 2021, and January 11, 2022. They found that individuals infected by stealth Omicron were 33% more likely to infect others, compared to original Omicron.
The study’s lead author Frederik Plesner Lyngse, PhD, told Reuters that “if you have been exposed to Omicron BA.2 in your household, you have 39% probability of being infected within seven days. If you instead had been exposed to BA.1, the probability is 29%.”
Lyngse said in a recent Tweet: “What is [Omicron] BA.2 and why do we care? Omicron BA.2 is genetically very different from BA.1. They differ by approximately 40 mutations.” He added that Morten Rasmussen, PhD, a researcher at Stanford University, “has told me told that BA.2 differs more from BA.1 genetically than [the Alfa variant of COVID-19] differs from the original Wuhan strain!”
Stealth Omicron has also been detected in the United States, Norway, the United Kingdom, and Sweden, but not to the extent that it’s been detected in Denmark where, as of the second week in January, it accounted for 82% of new COVID-19 cases.
Individuals who’ve been vaccinated and those vaccinated who’ve also gotten a booster are less likely to become infected by either Omicron or stealth Omicron, the study states.
“We found BA.2 to be associated with an increased susceptibility of infection for unvaccinated individuals (Odds Ratio (OR) 2.19; 95%-CI 1.58-3.04), fully vaccinated individuals (OR 2.45; 95%-CI 1.77-3.40) and booster-vaccinated individuals (OR 2.99; 95%-CI 2.11-4.24), compared to BA.1,” the study states. “We also found an increased transmissibility from unvaccinated primary cases in BA.2 households when compared to BA.1 households, with an OR of 2.62 (95%-CI 1.96-3.52).”
Omicron was first noticed in South Africa. Tulio de Oliveira, PhD, who directs South Africa's Centre for Epidemic Response and Innovation, said in a recent Tweet that while infections from stealth Omicron increase in that country, but against a “background of decreasing infections” COVID-19 infections overall.
Eric Topol, MD, founder and director of the Scripps Research Translational Institute, said in a recent Tweet that the study’s findings suggest that three doses of a vaccine offers good protection against “symptomatic infection,” but added that stealth Omicron’s “increased transmissibility will prolong the Omicron wave in many places.”
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.